Induced neural stem cells as a means of treatment in Huntington’s disease

References

• Maucksch C, Vazey EM, Gordon RJ, et al. Stem cell-based therapy for Huntington’s disease. J Cell Biochem. 2013;114(4):754–763.
   PubMed Web of Science ®Google Scholar
• Petersen A, Larsen KE, Behr GG, et al. Expanded CAG repeats in exon 1 of the Huntington’s disease gene stimulate dopamine-mediated striatal neuron autophagy and degeneration. Hum Mol Genet. 2001;10(12):1243–1254.
   PubMed Web of Science ®Google Scholar
• Walker FO. Huntington’s disease. Semin Neurol. 2007;27(2):143–150.
   PubMed Web of Science ®Google Scholar
• Walker FO. Huntington’s disease. Lancet. 2007;369(9557):218–228.
   PubMed Web of Science ®Google Scholar
• Ha AD, Fung VS. Huntington’s disease. Curr Opin Neurol. 2012;25(4):491–498.
   PubMed Web of Science ®Google Scholar
• Rosenblatt A, Kumar BV, Mo A, et al. Age, CAG repeat length, and clinical progression in Huntington’s disease. Mov Disord. 2012;27(2):272–276.
   PubMed Web of Science ®Google Scholar
• Li SH, Li XJ. Huntingtin-protein interactions and the pathogenesis of Huntington’s disease. Trends Genet. 2004;20(3):146–154.
   PubMed Web of Science ®Google Scholar
• DiFiglia M, Sapp E, Chase KO, et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science. 1997;277(5334):1990–1993.
   PubMed Web of Science ®Google Scholar
• Kazantsev A, Preisinger E, Dranovsky A, et al. Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells. Proc Natl Acad Sci U S A. 1999;96(20):11404–11409.
   PubMed Web of Science ®Google Scholar
• Martindale D, Hackam A, Wieczorek A, et al. Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates. Nat Genet. 1998;18(2):150–154.
   PubMed Web of Science ®Google Scholar
• Bennett EJ, Shaler TA, Woodman B, et al. Global changes to the ubiquitin system in Huntington’s disease. Nature. 2007;448(7154):704–708.
   PubMed Web of Science ®Google Scholar
• Landles C, Bates GP. Huntingtin and the molecular pathogenesis of Huntington’s disease. Fourth in molecular medicine review series. EMBO Rep. 2004;5(10):958–963.
   PubMed Web of Science ®Google Scholar
• Zuccato C, Ciammola A, Rigamonti D, et al. Loss of huntingtin-mediated BDNF gene transcription in Huntington’s disease. Science. 2001;293(5529):493–498.
   PubMed Web of Science ®Google Scholar
• Zuccato C, Tartari M, Crotti A, et al. Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes. Nat Genet. 2003;35(1):76–83.
   PubMed Web of Science ®Google Scholar
• Cha JH. Transcriptional signatures in Huntington’s disease. Prog Neurobiol. 2007;83(4):228–248.
   PubMed Web of Science ®Google Scholar
• Levi-Montalcini R, Hamburger V. Selective growth stimulating effects of mouse sarcoma on the sensory and sympathetic nervous system of the chick embryo. J Exp Zool. 1951;116(2):321–361.
   PubMedGoogle Scholar
• Tyebji S, Hannan AJ. Synaptopathic mechanisms of neurodegeneration and dementia: insights from Huntington’s disease. Prog Neurobiol. 2017;153:18–45.
   PubMed Web of Science ®Google Scholar
• Bartlett DM, Cruickshank TM, Hannan AJ, et al. Neuroendocrine and neurotrophic signaling in Huntington’s disease: implications for pathogenic mechanisms and treatment strategies. Neurosci Biobehav Rev. 2016;71:444–454.
   PubMed Web of Science ®Google Scholar
• Heinsen H, Rub U, Bauer M, et al. Nerve cell loss in the thalamic mediodorsal nucleus in Huntington’s disease. Acta Neuropathol. 1999;97(6):613–622.
   PubMed Web of Science ®Google Scholar
• Kassubek J, Juengling FD, Kioschies T, et al. Topography of cerebral atrophy in early Huntington’s disease: a voxel based morphometric MRI study. J Neurol Neurosurg Psychiatry. 2004;75(2):213–220.
   PubMed Web of Science ®Google Scholar
• Kremer HP, Roos RA, Dingjan G, et al. Atrophy of the hypothalamic lateral tuberal nucleus in Huntington’s disease. J Neuropathol Exp Neurol. 1990;49(4):371–382.
   PubMed Web of Science ®Google Scholar
• Rajkowska G, Selemon LD, Goldman-Rakic PS. Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease. Arch Gen Psychiatry. 1998;55(3):215–224.
   PubMed Web of Science ®Google Scholar
• Ransome MI, Renoir T, Hannan AJ. Hippocampal neurogenesis, cognitive deficits and affective disorder in Huntington’s disease. Neural Plast. 2012;2012:874387.
   PubMed Web of Science ®Google Scholar
• Vonsattel JP, DiFiglia M. Huntington disease. J Neuropathol Exp Neurol. 1998;57(5):369–384.
   PubMed Web of Science ®Google Scholar
• Lange H, Thorner G, Hopf A, et al. Morphometric studies of the neuropathological changes in choreatic diseases. J Neurol Sci. 1976;28(4):401–425.
   PubMed Web of Science ®Google Scholar
• Vonsattel JP, Myers RH, Stevens TJ, et al. Neuropathological classification of Huntington’s disease. J Neuropathol Exp Neurol. 1985;44(6):559–577.
   PubMed Web of Science ®Google Scholar
• Frank S. Treatment of Huntington’s disease. Neurotherapeutics. 2014;11(1):153–160.
   PubMed Web of Science ®Google Scholar
• Graveland GA, Williams RS, DiFiglia M. Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington’s disease. Science. 1985;227(4688):770–773.
   PubMed Web of Science ®Google Scholar
• Reiner A, Albin RL, Anderson KD, et al. Differential loss of striatal projection neurons in Huntington disease. Proc Natl Acad Sci U S A. 1988;85(15):5733–5737.
   PubMed Web of Science ®Google Scholar
• Fong CY, Gauthaman K, Bongso A. Teratomas from pluripotent stem cells: A clinical hurdle. J Cell Biochem. 2010;111(4):769–781.
   PubMed Web of Science ®Google Scholar
• Blum B, Benvenisty N. The tumorigenicity of human embryonic stem cells. Adv Cancer Res. 2008;100:133–158.
   PubMed Web of Science ®Google Scholar
• Ben-David U, Benvenisty N. The tumorigenicity of human embryonic and induced pluripotent stem cells. Nat Rev Cancer. 2011;11(4):268–277.
   PubMed Web of Science ®Google Scholar
• Miura K, Okada Y, Aoi T, et al. Variation in the safety of induced pluripotent stem cell lines. Nat Biotechnol. 2009;27(8):743–745.
   PubMed Web of Science ®Google Scholar
• Doetsch F. A niche for adult neural stem cells. Curr Opin Genet Dev. 2003;13(5):543–550.
   PubMed Web of Science ®Google Scholar
• Meirelles Lda S, Nardi NB. Murine marrow-derived mesenchymal stem cell: isolation, in vitro expansion, and characterization. Br J Haematol. 2003;123(4):702–711.
   PubMed Web of Science ®Google Scholar
• Loeffler M, Roeder I. Tissue stem cells: definition, plasticity, heterogeneity, self-organization and models–a conceptual approach. Cells Tissues Organs. 2002;171(1):8–26.
   PubMed Web of Science ®Google Scholar
• Verfaillie CM. Multipotent adult progenitor cells: an update. Novartis Found Symp. 2005;265:55–61; discussion 61–5, 92–7.
   PubMedGoogle Scholar
• Ma K, Fox L, Shi G, et al. Generation of neural stem cell-like cells from bone marrow-derived human mesenchymal stem cells. Neurol Res. 2011;33(10):1083–1093.
   PubMed Web of Science ®Google Scholar
• Huang Y, Tan S. Direct lineage conversion of astrocytes to induced neural stem cells or neurons. Neurosci Bull. 2015;31(3):357–367.
   PubMed Web of Science ®Google Scholar
• Corti S, Nizzardo M, Simone C, et al. Direct reprogramming of human astrocytes into neural stem cells and neurons. Exp Cell Res. 2012;318(13):1528–1541.
   PubMed Web of Science ®Google Scholar
• Han YC, Lim Y, Duffieldl MD, et al. Direct reprogramming of mouse fibroblasts to neural stem cells by small molecules. Stem Cells Int. 2016;2016:4304916.
   PubMed Web of Science ®Google Scholar
• Han DW, Tapia N, Hermann A, et al. Direct reprogramming of fibroblasts into neural stem cells by defined factors. Cell Stem Cell. 2012;10(4):465–472.
   PubMed Web of Science ®Google Scholar
• Suzuki H, Taguchi T, Tanaka H, et al. Neurospheres induced from bone marrow stromal cells are multipotent for differentiation into neuron, astrocyte, and oligodendrocyte phenotypes. Biochem Biophys Res Commun. 2004;322(3):918–922.
   PubMed Web of Science ®Google Scholar
• Hermann A, Gastl R, Liebau S, et al. Efficient generation of neural stem cell-like cells from adult human bone marrow stromal cells. J Cell Sci. 2004;117(Pt 19):4411–4422.
   PubMed Web of Science ®Google Scholar
• Lee J, Elkahloun AG, Messina SA, et al. Cellular and genetic characterization of human adult bone marrow-derived neural stem-like cells: a potential antiglioma cellular vector. Cancer Res. 2003;63(24):8877–8889.
   PubMed Web of Science ®Google Scholar
• Bantubungi K, Blum D, Cuvelier L, et al. Stem cell factor and mesenchymal and neural stem cell transplantation in a rat model of Huntington’s disease. Mol Cell Neurosci. 2008;37(3):454–470.
   PubMed Web of Science ®Google Scholar
• Lee ST, Park JE, Lee K, et al. Noninvasive method of immortalized neural stem-like cell transplantation in an experimental model of Huntington’s disease. J Neurosci Methods. 2006;152(1–2):250–254.
   PubMed Web of Science ®Google Scholar
• Vazey EM, Chen K, Hughes SM, et al. Transplanted adult neural progenitor cells survive, differentiate and reduce motor function impairment in a rodent model of Huntington’s disease. Exp Neurol. 2006;199(2):384–396.
   PubMed Web of Science ®Google Scholar
• Vazey EM, Dottori M, Jamshidi P, et al. Comparison of transplant efficiency between spontaneously derived and noggin-primed human embryonic stem cell neural precursors in the quinolinic acid rat model of Huntington’s disease. Cell Transplant. 2010;19(8):1055–1062.
   PubMed Web of Science ®Google Scholar
• Ryu JK, Kim J, Cho SJ, et al. Proactive transplantation of human neural stem cells prevents degeneration of striatal neurons in a rat model of Huntington disease. Neurobiol Dis. 2004;16(1):68–77.
   PubMed Web of Science ®Google Scholar
• Johann V, Schiefer J, Sass C, et al. Time of transplantation and cell preparation determine neural stem cell survival in a mouse model of Huntington’s disease. Exp Brain Res. 2007;177(4):458–470.
   PubMed Web of Science ®Google Scholar
• Lee ST, Chu K, Park JE, et al. Intravenous administration of human neural stem cells induces functional recovery in Huntington’s disease rat model. Neurosci Res. 2005;52(3):243–249.
   PubMed Web of Science ®Google Scholar
• McBride JL, Behrstock SP, Chen EY, et al. Human neural stem cell transplants improve motor function in a rat model of Huntington’s disease. J Comp Neurol. 2004;475(2):211–219.
   PubMed Web of Science ®Google Scholar
• Barker RA, Mason SL, Harrower TP, et al. The long-term safety and efficacy of bilateral transplantation of human fetal striatal tissue in patients with mild to moderate Huntington’s disease. J Neurol Neurosurg Psychiatry. 2013;84(6):657–665.
   PubMed Web of Science ®Google Scholar
• Roberts TJ, Price J, Williams SC, et al. Preservation of striatal tissue and behavioral function after neural stem cell transplantation in a rat model of Huntington’s disease. Neuroscience. 2006;139(4):1187–1199.
   PubMed Web of Science ®Google Scholar
• Casarosa S, Bozzi Y, Conti L. Neural stem cells: ready for therapeutic applications? Mol Cell Ther. 2014;2:31.
   PubMedGoogle Scholar
• Maisel M, Herr A, Milosevic J, et al. Transcription profiling of adult and fetal human neuroprogenitors identifies divergent paths to maintain the neuroprogenitor cell state. Stem Cells. 2007;25(5):1231–1240.
   PubMed Web of Science ®Google Scholar
• Aubry L, Bugi A, Lefort N, et al. Striatal progenitors derived from human ES cells mature into DARPP32 neurons in vitro and in quinolinic acid-lesioned rats. Proc Natl Acad Sci U S A. 2008;105(43):16707–16712.
   PubMed Web of Science ®Google Scholar
• Ma L, Hu B, Liu Y, et al. Human embryonic stem cell-derived GABA neurons correct locomotion deficits in quinolinic acid-lesioned mice. Cell Stem Cell. 2012;10(4):455–464.
   PubMed Web of Science ®Google Scholar
• Li XJ, Zhang X, Johnson MA, et al. Coordination of sonic hedgehog and Wnt signaling determines ventral and dorsal telencephalic neuron types from human embryonic stem cells. Development. 2009;136(23):4055–4063.
   PubMed Web of Science ®Google Scholar
• Nicoleau C, Varela C, Bonnefond C, et al. Embryonic stem cells neural differentiation qualifies the role of Wnt/beta-Catenin signals in human telencephalic specification and regionalization. Stem Cells. 2013;31(9):1763–1774.
   PubMed Web of Science ®Google Scholar
• Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663–676.
   PubMed Web of Science ®Google Scholar
• Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131(5):861–872.
   PubMed Web of Science ®Google Scholar
• Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;318(5858):1917–1920.
   PubMed Web of Science ®Google Scholar
• Jeon I, Lee N, Li JY, et al. Neuronal properties, in vivo effects, and pathology of a Huntington’s disease patient-derived induced pluripotent stem cells. Stem Cells. 2012;30(9):2054–2062.
   PubMed Web of Science ®Google Scholar
• Park IH, Arora N, Huo H, et al. Disease-specific induced pluripotent stem cells. Cell. 2008;134(5):877–886.
   PubMed Web of Science ®Google Scholar
• Zhang N, An MC, Montoro D, et al. Characterization of human Huntington’s disease cell model from induced pluripotent stem cells. PLoS Curr. 2010;2:RRN1193.
   PubMedGoogle Scholar
• Camnasio S, Delli Carri A, Lombardo A, et al. The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington’s disease patients demonstrates mutation related enhanced lysosomal activity. Neurobiol Dis. 2012;46(1):41–51.
   PubMed Web of Science ®Google Scholar
• Consortium H. Induced pluripotent stem cells from patients with Huntington’s disease show CAG-repeat-expansion-associated phenotypes. Cell Stem Cell. 2012;11(2):264–278.
   PubMed Web of Science ®Google Scholar
• An MC, Zhang N, Scott G, et al. Genetic correction of Huntington’s disease phenotypes in induced pluripotent stem cells. Cell Stem Cell. 2012;11(2):253–263.
   PubMed Web of Science ®Google Scholar
• Ambasudhan R, Talantova M, Coleman R, et al. Direct reprogramming of adult human fibroblasts to functional neurons under defined conditions. Cell Stem Cell. 2011;9(2):113–118.
   PubMed Web of Science ®Google Scholar
• Nam YJ, Song K, Luo X, et al. Reprogramming of human fibroblasts toward a cardiac fate. Proc Natl Acad Sci U S A. 2013;110(14):5588–5593.
   PubMed Web of Science ®Google Scholar
• Zhang K, Liu GH, Yi F, et al. Direct conversion of human fibroblasts into retinal pigment epithelium-like cells by defined factors. Protein Cell. 2014;5(1):48–58.
   PubMed Web of Science ®Google Scholar
• Vierbuchen T, Ostermeier A, Pang ZP, et al. Direct conversion of fibroblasts to functional neurons by defined factors. Nature. 2010;463(7284):1035–1041.
   PubMed Web of Science ®Google Scholar
• Pang ZP, Yang N, Vierbuchen T, et al. Induction of human neuronal cells by defined transcription factors. Nature. 2011;476(7359):220–223.
   PubMed Web of Science ®Google Scholar
• Yoo AS, Sun AX, Li L, et al. MicroRNA-mediated conversion of human fibroblasts to neurons. Nature. 2011;476(7359):228–231.
   PubMed Web of Science ®Google Scholar
• Caiazzo M, Dell’Anno MT, Dvoretskova E, et al. Direct generation of functional dopaminergic neurons from mouse and human fibroblasts. Nature. 2011;476(7359):224–227.
   PubMed Web of Science ®Google Scholar
• Pfisterer U, Kirkeby A, Torper O, et al. Direct conversion of human fibroblasts to dopaminergic neurons. Proc Natl Acad Sci U S A. 2011;108(25):10343–10348.
   PubMed Web of Science ®Google Scholar
• Liu X, Li F, Stubblefield EA, et al. Direct reprogramming of human fibroblasts into dopaminergic neuron-like cells. Cell Res. 2012;22(2):321–332.
   PubMed Web of Science ®Google Scholar
• Son EY, Ichida JK, Wainger BJ, et al. Conversion of mouse and human fibroblasts into functional spinal motor neurons. Cell Stem Cell. 2011;9(3):205–218.
   PubMed Web of Science ®Google Scholar
• Victor MB, Richner M, Hermanstyne TO, et al. Generation of human striatal neurons by microRNA-dependent direct conversion of fibroblasts. Neuron. 2014;84(2):311–323.
   PubMed Web of Science ®Google Scholar
• Kim J, Efe JA, Zhu S, et al. Direct reprogramming of mouse fibroblasts to neural progenitors. Proc Natl Acad Sci U S A. 2011;108(19):7838–7843.
   PubMed Web of Science ®Google Scholar
• Lujan E, Chanda S, Ahlenius H, et al. Direct conversion of mouse fibroblasts to self-renewing, tripotent neural precursor cells. Proc Natl Acad Sci U S A. 2012;109(7):2527–2532.
   PubMed Web of Science ®Google Scholar
• Sheng C, Zheng Q, Wu J, et al. Direct reprogramming of Sertoli cells into multipotent neural stem cells by defined factors. Cell Res. 2012;22(1):208–218.
   PubMed Web of Science ®Google Scholar
• Thier M, Worsdorfer P, Lakes YB, et al. Direct conversion of fibroblasts into stably expandable neural stem cells. Cell Stem Cell. 2012;10(4):473–479.
   PubMed Web of Science ®Google Scholar
• Ring KL, Tong LM, Balestra ME, et al. Direct reprogramming of mouse and human fibroblasts into multipotent neural stem cells with a single factor. Cell Stem Cell. 2012;11(1):100–109.
   PubMed Web of Science ®Google Scholar
• Zhu S, Ambasudhan R, Sun W, et al. Small molecules enable OCT4-mediated direct reprogramming into expandable human neural stem cells. Cell Res. 2014;24(1):126–129.
   PubMed Web of Science ®Google Scholar
• Zou Q, Yan Q, Zhong J, et al. Direct conversion of human fibroblasts into neuronal restricted progenitors. J Biol Chem. 2014;289(8):5250–5260.
   PubMed Web of Science ®Google Scholar
• Yu KR, Shin JH, Kim JJ, et al. Rapid and efficient direct conversion of human adult somatic cells into neural stem cells by HMGA2/let-7b. Cell Rep. 2015;10:441–452.
   Web of Science ®Google Scholar
• Hong JY, Lee SH, Lee SC, et al. Therapeutic potential of induced neural stem cells for spinal cord injury. J Biol Chem. 2014;289(47):32512–32525.
   PubMed Web of Science ®Google Scholar
• Yao H, Gao M, Ma J, et al. Transdifferentiation-induced neural stem cells promote recovery of middle cerebral artery stroke rats. PLoS One. 2015;10(9):e0137211.
   PubMed Web of Science ®Google Scholar
• Yamashita T, Liu W, Matsumura Y, et al. Novel therapeutic transplantation of induced neural stem cells for stroke. Cell Transplant. 2017;26(3):461–467.
   PubMed Web of Science ®Google Scholar
• Choi DH, Kim JH, Kim SM, et al. Therapeutic potential of induced neural stem cells for parkinson’s disease. Int J Mol Sci. 2017;18:1.
   Web of Science ®Google Scholar
• Maucksch C, Firmin E, Butler-Munro C, et al. Non-viral generation of neural precursor-like cells from adult human fibroblasts. J Stem Cells Regen Med. 2012;8(3):162–170.
   PubMedGoogle Scholar
• Capetian P, Azmitia L, Pauly MG, et al. Plasmid-based generation of induced neural stem cells from adult human fibroblasts. Front Cell Neurosci. 2016;10:245.
   PubMed Web of Science ®Google Scholar
• Kim SM, Kim JW, Kwak TH, et al. Generation of integration-free induced neural stem cells from mouse fibroblasts. J Biol Chem. 2016;291(27):14199–14212.
   PubMed Web of Science ®Google Scholar
• Hu W, Qiu B, Guan W, et al. Direct conversion of normal and Alzheimer’s disease human fibroblasts into neuronal cells by small molecules. Cell Stem Cell. 2015;17(2):204–212.
   PubMed Web of Science ®Google Scholar
• Zhang M, Lin YH, Sun YJ, et al. Pharmacological reprogramming of fibroblasts into neural stem cells by signaling-directed transcriptional activation. Cell Stem Cell. 2016;18(5):653–667.
   PubMed Web of Science ®Google Scholar
• Zheng J, Choi KA, Kang PJ, et al. A combination of small molecules directly reprograms mouse fibroblasts into neural stem cells. Biochem Biophys Res Commun. 2016;476(1):42–48.
   PubMed Web of Science ®Google Scholar
• Gao R, Xiu W, Zhang L, et al. Direct induction of neural progenitor cells transiently passes through a partially reprogrammed state. Biomaterials. 2017;119:53–67.
   PubMed Web of Science ®Google Scholar
• Hemmer K, Zhang M, van Wullen T, et al. Induced neural stem cells achieve long-term survival and functional integration in the adult mouse brain. Stem Cell Reports. 2014;3(3):423–431.
   PubMed Web of Science ®Google Scholar
• Ruggieri M, Riboldi G, Brajkovic S, et al. Induced neural stem cells: methods of reprogramming and potential therapeutic applications. Prog Neurobiol. 2014;114:15–24.
   PubMed Web of Science ®Google Scholar
• Madhavan L, Collier TJ. A synergistic approach for neural repair: cell transplantation and induction of endogenous precursor cell activity. Neuropharmacology. 2010;58(6):835–844.
   PubMed Web of Science ®Google Scholar
• Kokaia Z, Martino G, Schwartz M, et al. Cross-talk between neural stem cells and immune cells: the key to better brain repair? Nat Neurosci. 2012;15(8):1078–1087.
   PubMed Web of Science ®Google Scholar
• Fink KD, Deng P, Torrest A, et al. Developing stem cell therapies for juvenile and adult-onset Huntington’s disease. Regen Med. 2015;10(5):623–646.
   PubMed Web of Science ®Google Scholar
• Li M, Rosser AE. Pluripotent stem cell-derived neurons for transplantation in Huntington’s disease. Prog Brain Res. 2017;230:263–281.
   PubMedGoogle Scholar
• Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284(5411):143–147.
   PubMed Web of Science ®Google Scholar
• Caplan AI, Bruder SP. Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. Trends Mol Med. 2001;7(6):259–264.
   PubMed Web of Science ®Google Scholar
• Bianco P, Riminucci M, Gronthos S, et al. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells. 2001;19(3):180–192.
   PubMed Web of Science ®Google Scholar
• Sanchez-Ramos J, Song S, Cardozo-Pelaez F, et al. Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp Neurol. 2000;164(2):247–256.
   PubMed Web of Science ®Google Scholar
• Woodbury D, Schwarz EJ, Prockop DJ, et al. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res. 2000;61(4):364–370.
   PubMed Web of Science ®Google Scholar
• Kopen GC, Prockop DJ, Phinney DG. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci U S A. 1999;96(19):10711–10716.
   PubMed Web of Science ®Google Scholar
• Zhao LR, Duan WM, Reyes M, et al. Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats. Exp Neurol. 2002;174(1):11–20.
   PubMed Web of Science ®Google Scholar
• Fu L, Zhu L, Huang Y, et al. Derivation of neural stem cells from mesenchymal stemcells: evidence for a bipotential stem cell population. Stem Cells Dev. 2008;17(6):1109–1121.
   PubMed Web of Science ®Google Scholar
• Qu TY, Dong XJ, Sugaya I, et al. Bromodeoxyuridine increases multipotency of human bone marrow-derived stem cells. Restor Neurol Neurosci. 2004;22(6):459–468.
   PubMed Web of Science ®Google Scholar
• Bossolasco P, Cova L, Calzarossa C, et al. Neuro-glial differentiation of human bone marrow stem cells in vitro. Exp Neurol. 2005;193(2):312–325.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Henderson D, Blackstad M, et al. Neuroectodermal differentiation from mouse multipotent adult progenitor cells. Proc Natl Acad Sci U S A. 2003;100(Suppl 1):11854–11860.
   PubMed Web of Science ®Google Scholar
• Dezawa M, Kanno H, Hoshino M, et al. Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation. J Clin Invest. 2004;113(12):1701–1710.
   PubMed Web of Science ®Google Scholar
• Zhu S, Wei W, Ding S. Chemical strategies for stem cell biology and regenerative medicine. Annu Rev Biomed Eng. 2011;13:73–90.
   PubMed Web of Science ®Google Scholar
• Ebrahimi B. Biological computational approaches: new hopes to improve (re)programming robustness, regenerative medicine and cancer therapeutics. Differentiation. 2016;92(1–2):35–40.
   PubMed Web of Science ®Google Scholar
• Ohi Y, Qin H, Hong C, et al. Incomplete DNA methylation underlies a transcriptional memory of somatic cells in human iPS cells. Nat Cell Biol. 2011;13(5):541–549.
   PubMed Web of Science ®Google Scholar
• Huntington Study G. Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial. Neurology. 2006;66(3):366–372.
   PubMed Web of Science ®Google Scholar
• Bonelli RM, Niederwieser G, Tribl GG, et al. High-dose olanzapine in Huntington’s disease. Int Clin Psychopharmacol. 2002;17(2):91–93.
   PubMed Web of Science ®Google Scholar
• Cong L, Ran FA, Cox D, et al. Multiplex genome engineering using CRISPR/Cas systems. Science. 2013;339(6121):819–823.
   PubMed Web of Science ®Google Scholar
• Mali P, Aach J, Stranges PB, et al. CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering. Nat Biotechnol. 2013;31(9):833–838.
   PubMed Web of Science ®Google Scholar
• Vasiliou SK, Diamandis EP, Church GM, et al. CRISPR-Cas9 system: opportunities and concerns. Clin Chem. 2016;62(10):1304–1311.
   PubMed Web of Science ®Google Scholar
• Schaefer KA, Wu WH, Colgan DF, et al. Unexpected mutations after CRISPR-Cas9 editing in vivo. Nat Methods. 2017;14(6):547–548.
   PubMed Web of Science ®Google Scholar
• Veenhuizen RB, Kootstra B, Vink W, et al. Coordinated multidisciplinary care for ambulatory Huntington’s disease patients. Evaluation of 18 months of implementation. Orphanet J Rare Dis. 2011;6:77.
   PubMed Web of Science ®Google Scholar
• Thompson JA, Cruickshank TM, Penailillo LE, et al. The effects of multidisciplinary rehabilitation in patients with early-to-middle-stage Huntington’s disease: a pilot study. Eur J Neurol. 2013;20(9):1325–1329.
   PubMed Web of Science ®Google Scholar
• Piira A, Van Walsem MR, Mikalsen G, et al. Effects of a one year intensive multidisciplinary rehabilitation program for patients with Huntington’s disease: a prospective intervention study. PLoS Curr. 2013;5:pii: ecurrents.hd.9504af71e0d1f87830c25c394be47027.
   Google Scholar
• Cruickshank TM, Thompson JA, Dominguez DJ, et al. The effect of multidisciplinary rehabilitation on brain structure and cognition in Huntington’s disease: an exploratory study. Brain Behav. 2015;5(2):e00312.
   PubMed Web of Science ®Google Scholar
• Pang TY, Stam NC, Nithianantharajah J, et al. Differential effects of voluntary physical exercise on behavioral and brain-derived neurotrophic factor expression deficits in Huntington’s disease transgenic mice. Neuroscience. 2006;141(2):569–584.
   PubMed Web of Science ®Google Scholar
• van Dellen A, Blakemore C, Deacon R, et al. Delaying the onset of Huntington’s in mice. Nature. 2000;404(6779):721–722.
   PubMed Web of Science ®Google Scholar
• Bachoud-Levi AC. Neural grafts in Huntington’s disease: viability after 10 years. Lancet Neurol. 2009;8(11):979–981.
   PubMed Web of Science ®Google Scholar
• Cicchetti F, Saporta S, Hauser RA, et al. Neural transplants in patients with Huntington’s disease undergo disease-like neuronal degeneration. Proc Natl Acad Sci U S A. 2009;106(30):12483–12488.
   PubMed Web of Science ®Google Scholar
• Pecho-Vrieseling E, Rieker C, Fuchs S, et al. Transneuronal propagation of mutant huntingtin contributes to non-cell autonomous pathology in neurons. Nat Neurosci. 2014;17(8):1064–1072.
   PubMed Web of Science ®Google Scholar
• Kordower JH, Dodiya HB, Kordower AM, et al. Transfer of host-derived alpha synuclein to grafted dopaminergic neurons in rat. Neurobiol Dis. 2011;43(3):552–557.
   PubMed Web of Science ®Google Scholar
• Dunnett SB, Carter RJ, Watts C, et al. Striatal transplantation in a transgenic mouse model of Huntington’s disease. Exp Neurol. 1998;154(1):31–40.
   PubMed Web of Science ®Google Scholar
• Bernreuther C, Dihne M, Johann V, et al. Neural cell adhesion molecule L1-transfected embryonic stem cells promote functional recovery after excitotoxic lesion of the mouse striatum. J Neurosci. 2006;26(45):11532–11539.
   PubMed Web of Science ®Google Scholar
• Bjorklund A, Lindvall O. Cell replacement therapies for central nervous system disorders. Nat Neurosci. 2000;3(6):537–544.
   PubMed Web of Science ®Google Scholar
• Lindvall O, Kokaia Z. Stem cells for the treatment of neurological disorders. Nature. 2006;441(7097):1094–1096.
   PubMed Web of Science ®Google Scholar